BOCA RATON, Fla.--()--As the ten-year anniversary of the halting of the controversial Women’s Health Initiative (WHI) approaches, the journal, Climacteric, by the International Menopause Society publishes a series of articles offering conclusive evidence that the benefits of hormone replacement therapy (HRT) outweigh the risks.
The WHI study began in 1991 to test the safety and efficacy of synthetic hormone therapy, not bioidentical. In July of 2002, data from the WHI suggested that therapy using synthetic estrogen and progestin (synthetic progesterone) increased the risk of heart disease, stroke and breast cancer in women compared with those taking a placebo. The study was promptly halted and left a foul stigma associated with hormone replacement therapy and millions of women without hope for relief from the symptoms of menopause. The physicians of BodyLogicMD, along with researchers and medical experts from around the country, continued to seek alternative solutions and understand the reasons behind these findings.
Large scale analyses and comparative research has found that the risks observed in the WHI study pertained primarily to women who began HRT after menopause, in fact, the majority of women in the HRT study were twelve years past menopause when treatment was initiated. The articles in the journal unveil a series of conclusive findings that HRT benefits supersede the risks, including lowering the risk of heart disease, stroke, colorectal cancer, breast cancer and improving bone density.
The physicians of BodyLogicMD have led the industry in providing safe and effective treatment through bioidentical hormone replacement therapy for women experiencing symptoms of menopause. The medical expertise offered by this group of highly-trained physicians ensures that patients embrace a healthy lifestyle, offering fitness regimens and nutritional plans to accompany hormone therapy.
Founded in 2003, BodyLogicMD physician-owned practices make up the nation’s largest and fastest growing network of the most highly-trained physicians specializing in bioidentical hormone replacement therapy. Integrated with fitness and nutrition, BodyLogicMD’s medically supervised programs are for men and women suffering from hormone imbalance associated with aging, including menopause and andropause.
BodyLogicMD comprises a network of physicians, who are pioneers of the anti-aging industry. The Chief Medical Officer of BodyLogicMD, Dr. Jen Landa, published her top-selling book in women’s health, The Sex Drive Solution for Women: Dr. Jen’s Power Plan to Fire-up Your Libido in January 2012. BodyLogicMD has also been featured as an expert resource on Oprah.com and in Suzanne Somers’ books, Knockout: Interviews with Doctors Who Are Curing Cancer and How to Prevent It and Break Through: Eight Steps to Wellness. Her third book, Ageless: The Naked Truth about Bioidentical Hormones dedicates an entire chapter to BodyLogicMD. The Florida Trend cover story in December 2009, featured BodyLogicMD as the national leader in the growing anti-aging industry. The BusinessWeek cover story in March 2006, features the BodyLogicMD start-up story.